Get the Stockscreener App
28.99
1.03%
-0.25
Virtus Lifesci Biotech Clinical Trials Etf stock is traded at $28.99, with a volume of 1,116.
It is down -1.03% in the last 24 hours and up +4.46% over the past month.
See More
Previous Close:
$29.24
Open:
$28.92
24h Volume:
1,116
Relative Volume:
0.60
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.10%
1M Performance:
+4.46%
6M Performance:
+3.76%
1Y Performance:
+49.39%
1-Day Range:
$28.89
$28.92
1-Week Range:
$28.43
$29.41
52-Week Range:
$16.91
$31.99
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
Name
Virtus Lifesci Biotech Clinical Trials Etf
Sector
Industry
Phone
-
Address
-
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Latest News
(BBC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
The 5 Best Biotech ETFs of 2024 - TradingView
When (BBC) Moves Investors should Listen - Stock Traders Daily
(BBC) Trading Signals - Stock Traders Daily
7 Best-Performing Biotech ETFs for October 2024 - NerdWallet
Long Term Trading Analysis for (BBC) - Stock Traders Daily
Viking Therapeutics, Inc. (VKTX): Biotech Breakthrough or Short Sellers’ Target? - Yahoo Finance
Where are the Opportunities in (VABS) - Stock Traders Daily
FYC: Smart Or Speculative Small-Cap Growth ETF? (NASDAQ:FYC) - Seeking Alpha
(BBC) Trading Advice - Stock Traders Daily
Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Trading Up 2% - Defense World
Where are the Opportunities in (BBC) - Stock Traders Daily
The Great Rotation: Just Getting Started? - ETF Trends
(BBC) Technical Pivots with Risk Controls - Stock Traders Daily
Time for Healthcare ETFs? - Yahoo Finance
Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Shares Up 3.1% - Defense World
TSLA-related ETFs among top performing ETFs on a 4-week performance base last week - Seeking Alpha
5 Top ETFs of Last Week - Yahoo Finance
Inflation Cools in June, Triggers Spike in Laggard ETFs - Markets Insider
UK house prices likely to rise modestly this year and into 2025, says Halifax - Yahoo News UK
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - MSN
(BBC) Proactive Strategies - Stock Traders Daily
3 ETF Areas Likely to be in Tight Spots Post Banking Crisis - Yahoo New Zealand News
Healthcare Sector Outperforming: 5 Best ETFs & Stocks QTD - Yahoo Singapore News
(BBC) Investment Analysis and Advice - Stock Traders Daily
Pharma Stocks Look Cheap. Here's One Way to Invest. - Barchart
Best ETF Areas of Last Week - Yahoo News UK
Pharma Stocks Look Cheap. Here's One Way To Invest. - Barchart
7 Best-Performing Biotech ETFs for June 2024 - NerdWallet
Biotech ETF (BBC) Hits a New 52-Week High - Yahoo Movies UK
(BBC) Trading Report - Stock Traders Daily
Biotech Wins Last Week: 5 Best ETFs - Yahoo Lifestyle Australia
Hong Kong Approves First Bitcoin and Ether ETFs: A Game-Changer in the Crypto Market - The Globe and Mail
UP Global Sourcing (LON:UPGS) Stock Price Up 5.3% - Defense World
Arrow Exploration (LON:AXL) Earns Buy Rating from Canaccord Genuity Group - Defense World
Virtus LifeSci Biotech Clinical Trials ETF (NYSEARCA:BBC) Trading Down 2% - Defense World
Cboe Global Markets surpasses 1,000 ETFs worldwide - The Globe and Mail
Tech Sector Boosted by Apple - The Globe and Mail
ETF Issuer: Bristol Gate Capital Partners Inc. - The Globe and Mail
The Impact of Bitcoin Halving on Investors and ETFs to Explore - The Globe and Mail
Last Week, Virtus LifeSci Biotech Clinical Trials ETF Climbed 10%. Why? - Opto RoW
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
Biotech ETFs Stage Solid Comeback at the Start of 2024 - Yahoo Finance
Top and Flop Industry ETFs of Q3 - Yahoo Lifestyle UK
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
4 Best ETF Areas of Last Week That Are Up At Least 5% - Yahoo New Zealand News
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - FA Mag
Biotech ETFs Rally as Global Blood Therapeutics Surges on Potential Pfizer Deal - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Yahoo New Zealand News
Biotech ETFs Are Making a Comeback - ETF Trends
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Financials Data
There is no financial data for Virtus Lifesci Biotech Clinical Trials Etf (BBC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):